Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 4:31:101290.
doi: 10.1016/j.bbrep.2022.101290. eCollection 2022 Sep.

Effect of intermittency factor on singlet oxygen and PGE2 formation in azulene-mediated photodynamic therapy: A preliminary study

Affiliations

Effect of intermittency factor on singlet oxygen and PGE2 formation in azulene-mediated photodynamic therapy: A preliminary study

Teerasak Damrongrungruang et al. Biochem Biophys Rep. .

Abstract

In photodynamic therapy, intermittent irradiation modes that incorporate an interval between pulses are believed to decrease the effect of hypoxia by permitting an interval of re-oxygenation. The effect of the irradiation intermittency factor (the ratio of the irradiation pulse time to the total irradiation time) on singlet oxygen formation and inflammatory cytokine production was examined using azulene as a photosensitizer. Effects of difference intermittency factor on singlet oxygen formation and inflammatory cytokine were examined. Azulene solutions (1/10 μM) were irradiated with a 638-nm 500 mW diode laser in fractionation (intermittency factor of 5 or 9) or continuous mode using 50 mW/cm2 at 4 or 8 J/cm2. Singlet oxygen measurement was performed using a dimethyl anthracene probe. Peripheral blood mononuclear cells (PBMC) were stimulated by 10 ng/ml rhTNF-α for 6 h, before addition of 1 and 10 μM azulene solutions and irradiation. PGE2 measurement was undertaken using a human PGE2 ELISA kit. Kruskal-Wallis with Dunn Bonferroni test was used for statistical analyses at p < 0.05.Irradiation of 1 μM azulene+4 J/cm2+intermittency factor of 9 increased singlet oxygen 3-fold (p < 0.0001). Irradiation of 10 μM azulene at either 4 J/cm2+intermittency of 9 or 8 J/cm2+intermittency factor of 5 reduced PGE2 expression in PBMCs to non-inflamed levels. Thus, at 50 mW/cm2, 10 μM azulene-mediated photodynamic therapy with a high intermittency factor and a low energy density generated sufficient singlet oxygen to suppress PGE2 in Inflamed PBMCs.

Keywords: Azulene; Inflammation; Intermittency factor; Photodynamic therapy; Pulse mode; Singlet oxygen.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Image 1
Graphical abstract
Fig. 1
Fig. 1
The 638 nm-diode laser irradiation apparatus. The irradiation box is composed of a black acrylic box with an irradiation chamber. Parts of machine composed of 1) electric circuit with laser light bulbs, 2) monitor connected with electric circuit, 3) parameter adjustment button, 4) machine reset hole, 5) operation indicating light, 6) light distraction plate, 7) light projection slit, 8) culture plate holder. This machine is connected with normal AC supply.
Fig. 2
Fig. 2
Relative singlet oxygen quantity in 1 μM azulene-mediated PDT using a power density of 50 mW/cm2, a) energy density of 4 or b) energy density of 8 J/cm2 from a 638 nm red laser and fractionation mode of irradiation (intermittency factor of 5 and 9 and continuous) and using 9,10-dimethylanthracene (DMA) as a singlet oxygen specific fluorescence probe. Positive control = continuous mode, negative control = non irradiation group. n = 12 * = significant difference at p-value < 0.05, a = significant difference from positive control at the same mode of light at p-value < 0.05 (Cont = continuous mode, Int = intermittency factor).
Fig. 3
Fig. 3
Relative singlet oxygen quantity in 10 μM azulene-mediated PDT using a power density of 50 mW/cm2, a) energy density of 4 or b) energy density of 8 J/cm2 from a 638 nm red laser and fractionation mode of irradiation (intermittency factor of 5 and 9 and continuous) and using 9,10-dimethylanthracene (DMA) as a singlet oxygen specific fluorescence probe. Positive control = continuous mode, negative control = non irradiation group. n = 12 * = significant difference at p-value < 0.05, a = significant difference from positive control at the same mode of light at p-value < 0.05 (Cont = continuous mode, Int = intermittency factor).
Fig. 4
Fig. 4
PGE2 quantity after a) 1 μM b) 10 μM azulene-mediated PDT using a power density of 50 mW/cm2, energy density of 4 or 8 J/cm2 from a 638 nm red laser and fractionation mode of irradiation (intermittency factor of 5 and 9 and continuous) treated rhTNFα-induced inflammatory peripheral blood mononuclear cells and competitive human ELISA kit for detection. Positive control = peripheral blood mononuclear cells pretreated with 50 μg/mL of indomethacin, Negative control = rhTNFα-induced inflammatory peripheral blood mononuclear cells. a = significant difference from Positive control at p-value < 0.05, b = significant difference from Negative control at p-value < 0.05, dot line = basal level PGE2 in non-inflamed cells, a = significant different from (Int = intermittency factor, +ve con = positive control, -ve con = negative control, n = 4).
Fig. 5
Fig. 5
Correlation between singlet oxygen and PGE2 in (a) intermittency factor 5, (b) intermittency factor 9, experiments were performed in triplicate fashion and duplicate for singlet oxygen and PGE2, respectively. Error bar = standard deviation of singlet oxygen amount.

Similar articles

Cited by

References

    1. Allison R.R., Motaa H.C., Bagnatob V.S., Sibata C.H. Bio-nanotechnology and photodynamic therapy—state of the art review. Photodiagnosis Photodyn. Ther. 2008;5:19–28. doi: 10.1016/j.pdpdt.2008.02.001. - DOI - PubMed
    1. Zhang Y., Wang F., Liu C., Wang Z., Kang L., Huang Y., Dong K., Ren J., Qu X. Nanozyme decorated metal-organic frameworks for enhanced photodynamic therapy. ACS Nano. 2018;12:651–661. doi: 10.1021/acsnano.7b07746. - DOI - PubMed
    1. Larue L., Myrzakhmetov B., Ben-Mihoub A., Moussaron A., Thomas N., Arnoux P., Baros F., Vanderesse R., Acherar S., Frochot C C. Fighting hypoxia to improve PDT. Pharmaceuticals. 2019;12:163. doi: 10.3390/ph12040163. - DOI - PMC - PubMed
    1. Wang K.K., Mitra S., Foster T.H. A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy Med. Phys. Nor. 2007;34:282–293. doi: 10.1118/1.2401041. - DOI - PubMed
    1. Kim M.M., Ghogare A.A., Greer A., Zhu T.C. On the in-vivo photochemical rate parameters for PDT reactive oxygen species modelling. Phys. Med. Biol. 2017;62 doi: 10.1088/1361-6560/62/5/R1. R1–R48. - DOI - PMC - PubMed

LinkOut - more resources